Latest news
Weekly Recap: MannKind (MNKD) Furoscix FDA clearance and Aug 5 Q2 call - TradingViewTradingView · Mon, 03 Aug 2026 11:33:16 GMTMannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload - Slideshow (NASDAQ:MNKD) 2026-07-31 - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTFDA approves at-home Furoscix ReadyFlow autoinjector - McKnight's Senior LivingMcKnight's Senior Living · Tue, 28 Jul 2026 07:00:00 GMT